Recombinant Mouse Cxcl12 Protein ，His

CXCL12, also known as stromal cell-derived factor 1 (SDF-1), is a chemokine that plays a crucial role in various physiological and pathological processes, including immune responses, hematopoiesis, and organ development. It is known for its ability to attract leukocytes to sites of injury or inflammation and is also implicated in cancer metastasis, as it can facilitate the migration of tumor cells. The study of CXCL12 recombinant protein has garnered significant attention due to its potential therapeutic applications. Researchers are investigating its use in regenerating damaged tissues, enhancing stem cell homing, and developing cancer immunotherapies. Recombinant CXCL12 is often produced using techniques such as recombinant DNA technology, allowing for the generation of a pure and functional form of the protein. This has enabled in-depth studies into its structure-function relationships, signaling pathways, and interactions with its receptor CXCR4. Understanding these dynamics is vital for exploiting CXCL12 in clinical settings, particularly in the treatment of diseases like cancer and in regenerative medicine. Furthermore, CXCL12's role in the tumor microenvironment highlights its significance in developing targeted therapies that could inhibit cancer progression while promoting healthy immune responses. Overall, the investigation of CXCL12 recombinant protein is positioned at the forefront of translational research, offering insights that may advance both therapeutic strategies and our fundamental understanding of cellular communication in health and disease.